- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
5
Companies available at a discount paying at least a 2% dividend yield.
5 companies
Johnson & Johnson
Market Cap: US$514.7b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$218.55
7D
5.3%
1Y
50.8%
Merck
Market Cap: US$268.7b
Operates as a healthcare company worldwide.
MRK
US$111.01
7D
2.2%
1Y
10.9%
Gilead Sciences
Market Cap: US$151.1b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$124.07
7D
-0.2%
1Y
34.3%
Pfizer
Market Cap: US$143.0b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$25.58
7D
1.2%
1Y
-2.4%
Qiagen
Market Cap: US$9.7b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$47.44
7D
-4.7%
1Y
-3.2%